< back to Directors and Advisors

Joel S. Ross, M.D., FACP, AGSF, CMD
Dr. Ross is the Founder, CEO, Primary Care Geriatrician and Principal Investigator at the Memory Enhancement Center of America in Long Branch, New Jersey. Dr. Ross served as Principal Investigator or Sub-investigator on nearly every Alzheimer's disease drug in clinical trials since 1994, including Ondansetron, Cognex, Donepezil, Exelon, Memantine and, most recently, Alzhemed (Neurochem) and ELN116727 (ELAN). He has a number of hospital appointments and Medical Directorships in the state of New Jersey. Dr. Ross received his undergraduate degree from Hofstra and his M.D. from Downstate Medical Center, Brooklyn, New York. He completed his internship and residency at Nassau County Medical Center East Meadow, New York, where he then became chief resident. He is certified in Geriatric Medicine and Internal Medicine and by the National Board of Medical Examiners.

 


  » Home
» News & Events
» Contact Us
ABOUT US
Management Team
Directors & Advisors
Collaborators
Memberships
TECHNOLOGY
Neurogenesis & Neuron Regeneration
Drug Discovery
Intellectual Property
R&D PROGRAMS
Alzheimer's Disease
Depression
Parkinson's Disease
Down Syndrome
Ischemia
Hibernation and Ischemia
  © 2016 NeuroNascent, Inc. - All Rights Reserved
This website contains forward-looking statements, which are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are commonly identified by words such as “would,” “may,” “will,” “expects,” and other terms with similar meaning. Forward-looking statements are based on current beliefs, assumptions and expectations and speak only as of the date of this site and involve risks and uncertainties that could cause actual results to differ materially from current expectations.